Ken Griffin Armata Pharmaceuticals, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 300 shares of ARMP stock, worth $564. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300Holding current value
$564% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding ARMP
# of Institutions
28Shares Held
740KCall Options Held
300Put Options Held
1K-
Vanguard Group Inc Valley Forge, PA260KShares$488,9370.0% of portfolio
-
Geode Capital Management, LLC Boston, MA106KShares$198,9730.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$188,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX44.7KShares$84,0020.0% of portfolio
-
State Street Corp Boston, MA40.3KShares$75,7640.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $68M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...